ArticleDigestive diseases and sciences2026
Comparison of Minimal Endoscopic Sphincterotomy with Balloon Dilation and Endoscopic Sphincterotomy for the Treatment of Small Common Bile Duct Stones: A Propensity-Matched Analysis.
Article in Digestive diseases and sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEndoscopic sphincterotomy (ES) with balloon dilation, combining minimal incision and controlled dilation (ESBD), has been proposed to balance safety and efficacy in treating small common bile duct (CBD) stones. This study aimed to compare the outcomes of ESBD and conventional ES in a large real-world cohort.
methodsThis retrospective study included 1,647 eligible patients (ESBD, n = 326; ES, n = 1,321) with ≤ 11 mm CBD stones who underwent endoscopic removal. Propensity score matching was performed (1:1, caliper 0.2), with 299 patients per group. The primary outcome was the rate of procedure-related adverse events (AEs), and secondary outcomes included complete stone removal, need for multiple sessions, use of lithotripsy, and procedure time for stone removal.
resultsThe AE rate was significantly lower in the ESBD group than in the ES group (4.0% vs. 8.7%, p = 0.028), particularly for bleeding (2.0% vs. 5.7%, p = 0.031). The incidence of pancreatitis was comparable between the groups. The procedure time for stone removal was significantly shorter in the ESBD group (median, 12 vs. 22 min; p < 0.001). The rates of complete stone removal, need for multiple sessions, and lithotripsy were similar between the groups. Multivariate analysis revealed that ESBD was significantly associated with a lower incidence of AEs (odds ratio, 0.43; p = 0.048).
conclusionsESBD significantly reduced bleeding and overall AEs without increasing the risk of pancreatitis while shortening the procedure time for stone removal. These findings support ESBD as a potentially safe, efficient, and practical alternative to conventional ES for removing small CBD stones.
Indexed as
Identifiers
41709055What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.